Title : Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial.

Pub. Date : 2020 Oct

PMID : 33117463

1 Functional Relationships(s)
Compound Name
Protein Name
1 Conclusions: Neoadjuvant chemotherapy using nab-PTX with trastuzumab every 3 weeks followed by FEC was suitably tolerated and associated with a high pCR rate of 55% for patients with HER2-positive breast cancer. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens